Skip to content

Effects of supplementation with orally effective Superoxide Dismutase, GliSODin, on oxidative stress, inflammation and performance in athletes

Evaluation of antioxidant and anti-inflammatory properties of orally effective plant origin Superoxide Dismutase, GliSODin, supplementation and its impact on performance in athletes

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000319774
Enrollment
54
Registered
2022-02-21
Start date
2020-12-16
Completion date
2021-09-03
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Intensive physical activity can cause oxidative stress witch is connected with some inflammation reaction and higher muscle fatigue and injury level so it can reduce performance of athletes. GliSODin is dietary supplement that contain plant origin superoxide dismutase (SOD). SOD is one of the main antioxidant enzymes in our body. In our randomized, double-blind, placebo-controlled study we were investigating if supplementation with GliSODin can reduce side effects of oxidative stress induced by intensive physical activity and increase physical performance of elite athletes or healthy fit people.

Interventions

Supplementation with plant origin superoxide dismutase (GliSODin) in a randomized, double-blind, placebo controlled study conducted to assess the effects of supplementation on exercise-induced oxidative stress, exercise-induced inflammation and performance in athletes. Study included group of elite rowers and group of recreational athletes. For all rowers participating this study exercise performance was tested on rowing ergometer at the beginning of the study. Test on ergometer was conducted w

Supplementation with plant origin superoxide dismutase (GliSODin) in a randomized, double-blind, placebo controlled study conducted to assess the effects of supplementation on exercise-induced oxidative stress, exercise-induced inflammation and performance in athletes. Study included group of elite rowers and group of recreational athletes. For all rowers participating this study exercise performance was tested on rowing ergometer at the beginning of the study. Test on ergometer was conducted with increased exercise load. For males it was 2 minutes rowing with increasing load for every session like this: 150W (watt), 200W, 250W, 300W, 400W , and individual maximal effort, with 5 minutes pauses between session and 8 minutes pause before maximal effort attempt. For females load increased like this: 150W, 180W, 220W, 250W, 300W , and individual maximal effort, with same pause schema. Test on rowing ergometer lasted for 40 minutes. Rowers trainers and medical technician, beside research team, were monitoring the test. Same test was conduced after 6 weeks of supplementation. During this 6 weeks rowers were training according to the schedule determined by their trainers, once daily, 6 or 7 days a week, duration of every training session was 1 hour and 30 minutes. After initial testing, rowers have been taking GliSODin (250mg), 2 capsules every day, one hour before training on days with training or one hour before breakfast on days without training, during 6 weeks period. Sport performance of recreational athletes was tested at the beginning of the study on a treadmill machine. All athletes were running for 30 minutes on 70-75% of VO2max and after that they have done usual training in a gym. After initial testing, recreational athletes have been taking 2 capsules of GliSodin (250mg) only on the days they were having training (3 times a week), one hour before training, during 6 weeks. Training load was individualized for each athlete by personal coach with incremental increase in training load. Recreational athlete had 3 training sessions a week for 6 weeks, duration of sessions was 1 hour. All participant were asked to avoid using any other supplement or medicines. Every use of medicines must have been reported to research team. Intervention adherence was monitored by capsules returned to the research team and by trainers whose task was to lead the record of training for every participant.

Sponsors

Ivan Stankovic
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy elite athletes and healthy fit people without any acute infection, injury or some chronic diseases like diabetes, cardiovascular, renal or gastrointestinal diseases

Exclusion criteria

allergy to any component of dietary supplement, gluten intolerance, supplementation with other antioxidant supplement during the study and two weeks before study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026